sildenafil-citrate and Long-QT-Syndrome

sildenafil-citrate has been researched along with Long-QT-Syndrome* in 2 studies

Other Studies

2 other study(ies) available for sildenafil-citrate and Long-QT-Syndrome

Article	Year
PDE5 Inhibition Suppresses Ventricular Arrhythmias by Reducing SR Ca Circulation research, 2021, 09-03, Volume: 129, Issue:6 [Figure: see text]. Topics: Animals; Calcium; Calcium Signaling; Carbazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Long QT Syndrome; Phenethylamines; Phosphodiesterase 5 Inhibitors; Potassium Channel Blockers; Protein Kinase Inhibitors; Protein Kinases; Sarcoplasmic Reticulum; Sheep; Sildenafil Citrate; Sodium; Sulfonamides	2021
Syncope in a Child with Pulmonary Hypertension and Positive Gene Tests for Hereditary Hemorrhagic Telangiectasia and Long QT Syndrome. Cardiovascular & hematological agents in medicinal chemistry, 2020, Volume: 18, Issue:1 We present a 10-year-old boy with syncope who was found to have long-QT syndrome and severe Pulmonary Hypertension (PH) both in the absence of a secondary cause; to our knowledge, this is the first report with this unusual coexistence. His genetic tests were positive for hereditary hemorrhagic telangiectasia and Long QT Syndrome (LQTS) without any family history of PH or LQTS. We demonstrated that digital subtraction pulmonary angiography was more useful compared to CT angiogram to demonstrate pulmonary vascular changes which correlated with a noresponse to acute vasoreactivity testing during right heart catheterization. He has been stable for the last 2 years on Ambrisentan, Sildenafil, and Nadolol without recurrence of symptoms. Topics: Angiography; Child; Echocardiography; Electrocardiography; Genetic Testing; Humans; Hypertension, Pulmonary; Long QT Syndrome; Male; Nadolol; Phenylpropionates; Pyridazines; Sildenafil Citrate; Syncope; Telangiectasia, Hereditary Hemorrhagic; Tomography, X-Ray Computed	2020

Article

Year

PDE5 Inhibition Suppresses Ventricular Arrhythmias by Reducing SR Ca

Circulation research, 2021, 09-03, Volume: 129, Issue:6

[Figure: see text].

Topics: Animals; Calcium; Calcium Signaling; Carbazoles; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Long QT Syndrome; Phenethylamines; Phosphodiesterase 5 Inhibitors; Potassium Channel Blockers; Protein Kinase Inhibitors; Protein Kinases; Sarcoplasmic Reticulum; Sheep; Sildenafil Citrate; Sodium; Sulfonamides

2021

Syncope in a Child with Pulmonary Hypertension and Positive Gene Tests for Hereditary Hemorrhagic Telangiectasia and Long QT Syndrome.

Cardiovascular & hematological agents in medicinal chemistry, 2020, Volume: 18, Issue:1

We present a 10-year-old boy with syncope who was found to have long-QT syndrome and severe Pulmonary Hypertension (PH) both in the absence of a secondary cause; to our knowledge, this is the first report with this unusual coexistence. His genetic tests were positive for hereditary hemorrhagic telangiectasia and Long QT Syndrome (LQTS) without any family history of PH or LQTS. We demonstrated that digital subtraction pulmonary angiography was more useful compared to CT angiogram to demonstrate pulmonary vascular changes which correlated with a noresponse to acute vasoreactivity testing during right heart catheterization. He has been stable for the last 2 years on Ambrisentan, Sildenafil, and Nadolol without recurrence of symptoms.

Topics: Angiography; Child; Echocardiography; Electrocardiography; Genetic Testing; Humans; Hypertension, Pulmonary; Long QT Syndrome; Male; Nadolol; Phenylpropionates; Pyridazines; Sildenafil Citrate; Syncope; Telangiectasia, Hereditary Hemorrhagic; Tomography, X-Ray Computed

2020